Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance

IMPORTANCE: Little is known about how out-of-pocket burden differs between Medicare and commercial insurance for ultra-expensive drugs. OBJECTIVE: To investigate out-of-pocket spending for ultra-expensive drugs in the Medicare Part D program vs commercial insurance. DESIGN, SETTING, AND PARTICIPANTS...

Descripción completa

Detalles Bibliográficos
Autores principales: DiStefano, Michael J., Kang, So-Yeon, Parasrampuria, Sonal, Anderson, Gerard F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220512/
https://www.ncbi.nlm.nih.gov/pubmed/37234016
http://dx.doi.org/10.1001/jamahealthforum.2023.1090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220512/
https://www.ncbi.nlm.nih.gov/pubmed/37234016
http://dx.doi.org/10.1001/jamahealthforum.2023.1090

Ejemplares similares